Breakthroughs Blog

Breakthroughs brings you stories of bright ideas and bold innovations in global health.

The Latest
Ansley Kahn
Research Roundup: Single-dose Ebola drug, mosquito birth control, and new TB treatment

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

Recent

Investing in the future: GHTC congressional briefing highlights compelling benefits of global health research

“I’d be careful not to break something that would be hard to put back together,” Alan Magill—director of Malaria at the Bill & Melinda Gates Foundation—said this week at the GHTC’s annual congressional briefing.

GHTC
Read More
Architect of the Capitol
GHTC 2013 report: Clear steps for policymakers to renew the US legacy in global health R&D

We have long known that Washington is operating under a remarkably unorthodox budgetary process.

GHTC
Read More
PATH/Gabe Bienczycki
Research Roundup: What we’re reading this week

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

GHTC
Read More
A chorus of voices across the government calls for a solution to sequestration

During last week’s State of the Union address, President Obama called on policymakers to find a solution to the federal budget debate before sequestration—or widespread and indiscriminate cuts to all federal programs—takes place next month.

GHTC
Read More
PATH/Gabe Bienczycki
Research Roundup: What we’re reading this week

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

GHTC
Read More
PATH/Aaron Joel Santos
Research Roundup: What we’re reading this week

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

GHTC
Read More
Obama begins second term with new faces, changing leadership in key global health positions

President Obama officially began his second term in office this week, and will have a host of new faces to work with in Congress and his own administration.

GHTC
Read More
PATH/Gabe Bienczycki
Research Roundup: What we’re reading this week

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

GHTC
Read More
Halting the fiscal cliff: How will the latest budget negotiations impact global health and development?

Going into December 2012, Congress had neither completed its work on the federal budget for fiscal year (FY) 2013 nor decided how to avoid sequestration—widespread and indiscriminate cuts to all federal programs.

GHTC
Read More
PATH/Patrick McKern
Research Roundup: What we’re reading this week

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

GHTC
Read More
PATH
FDA approval of new TB drug benefits patients and highlights the agency’s lifesaving programs

The New Year has brought some much-needed good news in the fight against tuberculosis (TB). The US Food and Drug Administration (FDA) recently announced that it has approved a new treatment for multidrug-resistant TB that can be used as an alternative when other drugs fail.

GHTC
Read More
PATH/Gabe Bienczycki
Funding for global health R&D: good news and bad

Sometimes the best news is no news at all. That’s one of the thoughts that struck me while pondering the results of the latest G-FINDER survey on global funding of R&D for neglected diseases.

Policy Cures
Read More
PATH/Doune Porter
Research Roundup: What we’re reading this week

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

GHTC
Read More
PATH/Francesca Holme
Research Roundup: What we’re reading this week

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

GHTC
Read More
CDC/ Prof. Woodbridge Foster; Prof. Frank H. Collins
Changing our definition of neglected diseases: Is it time to think beyond traditional terms?

Depending on who you ask, you’ll come up with a number of different definitions for what exactly characterizes a neglected disease, as there’s no generally accepted definition.

GHTC
Read More
Reaching an AIDS-free generation: Why research and new tools must be part of the solution

Ahead of World AIDS Day, Secretary of State Hillary Rodham Clinton launched a new State Department blueprint to reach an “AIDS-free generation” within five years.

GHTC
Read More
PATH/Aaron Joel Santos
Research Roundup: What we’re reading this week

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

GHTC
Read More
PATH
Developing new tools to fight TB: New report examines state of TB R&D

Mycobacterium tuberculosis is one of the oldest known human pathogens that continues to pose a global public health threat in the 21st century.

Treatment Action Group
Read More
PATH/Nguyen Ba Quang
Research Roundup: What we’re reading this week

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

GHTC
Read More
On childhood TB, time for ACTION

In this guest post, Mandy Slutsker, senior project associate with the ACTION Partnership, writes about a new report that calls for increased efforts to fight tuberculosis among children worldwide.

ACTION Partnership
Read More